Predictive value of eTag dimerization assay in patients with metastatic colorectal cancer treated with erlotinib.

被引:0
|
作者
Oza, AM
Townsley, CA
Pond, G
Singh, S
Siu, LL
机构
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Aclara Inc, Mountain View, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:865S / 865S
页数:1
相关论文
共 50 条
  • [41] Identification of enterotype and its predictive value for patients with colorectal cancer
    Li Qingbo
    Zhuang Jing
    Qu Zhanbo
    Chu Jian
    Song Yifei
    Wu Yinhang
    Han Shuwen
    Gut Pathogens, 16
  • [42] Predictive and prognostic factors in metastatic colorectal cancer patients treated with fruquintinib: A multicenter real-world analysis
    Zhang, C.
    Wang, Y.
    Xu, J.
    Dong, M.
    Liu, K.
    Lu, Y.
    Chen, K.
    Cao, Y.
    Shi, H.
    Bei, Y.
    Li, J.
    Zhao, J.
    Cao, Y.
    Lu, N.
    Liu, H.
    Cai, P.
    Li, K.
    Yang, T.
    He, N.
    Dong, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S44 - S44
  • [43] High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib
    Amatu, Alessio
    Schirripa, Marta
    Tosi, Federica
    Lonardi, Sara
    Bencardino, Katia
    Bonazzina, Erica
    Palmeri, Laura
    Patane, Damiano Alfio
    Pizzutilo, Elio Gregory
    Mussolin, Benedetta
    Bergamo, Francesca
    Alberti, Giulia
    Intini, Rossana
    Procaccio, Letizia
    Arese, Marco
    Marsoni, Silvia
    Nichelatti, Michele
    Zagonel, Vittorina
    Siena, Salvatore
    Loupakis, Fotios
    Di Nicolantonio, Federica
    Sartore-Bianchi, Andrea
    Barault, Ludovic
    Bardelli, Alberto
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [44] THE PREDICTIVE VALUE OF MIRNA-126 IN RELATION TO FIRST LINE CAPECITABINE AND OXALIPLATIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Hansen, Torben
    Sorensen, Flemming
    Lindebjerg, Jan
    Jakobsen, Anders
    ANNALS OF ONCOLOGY, 2011, 22 : v98 - v99
  • [45] Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer
    Okazaki, Satoshi
    Stintzing, Sebastian
    Sunakawa, Yu
    Cao, Shu
    Zhang, Wu
    Yang, Dongyun
    Ning, Yan
    Matsusaka, Satoshi
    Berger, Martin D.
    Miyamoto, Yuji
    Suenaga, Mitsukuni
    Schirripa, Marta
    West, Jordan D.
    Gopez, Roel
    Akihito, Tsuji
    Ichikawa, Wataru
    Heinemann, Volker
    DePaolo, R. William
    Lenz, Heinz-Josef
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (06) : 1222 - 1230
  • [46] Factors predictive of response and survival in patients with metastatic colorectal cancer in Taiwan
    Wang, WS
    Fan, FS
    Hsieh, RK
    Chiou, TJ
    Lin, JK
    Lin, TC
    Yen, CC
    Liu, JH
    Hsu, H
    Chen, PM
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) : 174 - 179
  • [47] Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers
    Kasi, Pashtoon Murtaza
    Hubbard, Joleen M.
    Grothey, Axel
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (03) : 273 - 276
  • [48] Predictive biomarkers of response to cetuximab in Chinese patients with metastatic colorectal cancer
    Ma, Brigette
    Loong, Herbert
    Liem, Giok Siong
    Mo, Frankie
    Tong, Joanna
    Wong, S. C. Cesar
    Chan, Anthony T. C.
    To, Ka Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib
    Liu, Yingmiao
    Lyu, Jing
    Burdett, Kirsten Bell
    Sibley, Alexander B.
    Hatch, Ace J.
    Starr, Mark D.
    Brady, John C.
    Hammond, Kelli
    Marmorino, Federica
    Rossini, Daniele
    Goldberg, Richard M.
    Falcone, Alfredo
    Cremolini, Chiara
    Owzar, Kouros
    Ivanova, Anastasia
    Moore, Dominic T.
    Lee, Michael S.
    Sanoff, Hanna K.
    Innocenti, Federico
    Nixon, Andrew B.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2146 - 2154
  • [50] Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy
    Schuster, Cornelia
    Akslen, Lars A.
    Stokowy, Tomasz
    Straume, Oddbjorn
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2019, 5 (01): : 53 - 62